(Alliance News) - British Steel announced on Tuesday it has halted plans to lay off thousands of workers after the government secured the raw materials necessary to keep Britain's last steelmaking ...

Against the yen, the dollar was trading lower at JPY140.73 on Tuesday at the London equities close compared to JPY142.19 on Thursday. As recently as April 2, the dollar traded above JPY150. The euro ...

(Alliance News) - Regent Acquisitions 2025 Ltd on Tuesday said it has made an offer to buy Inspired PLC, in a transaction valuing the company at GBP109.4 million. Inspired is an Isle of Man-based ...

Focus Xplore is a strategic energy and critical minerals exploration company with exploration programs in Ontario, Canada. Fladgate has been appointed to complete mapping and sampling activities at ...

The DMC deal was initially agreed in December, and would have seen DMC make a GBP19 million capital investment via Valereum Inc, an entity formed for the purpose of the investment.

The Canada-focused exploration firm said the gallium averages at around 17 grammes per tonne, and has the potential to "significantly increase" the value of its prospective projects, positioning them ...

(Alliance News) - Admiral Group PLC on Tuesday said it has agreed to sell its US motor insurance business to private investment firm JC Flowers & Co for an undisclosed fee. The Cardiff, Wales-based ...

(Alliance News) - Gelion PLC on Tuesday said it has executed a materials testing deal with an unnamed tier-one battery manufacturer, following its agreement to the terms on Thursday last week.

US President Donald Trump unveiled plans earlier this month to hike tariffs and introduce new levies on all goods being imported. This included a baseline 10% tariff for most countries, including the ...

[Alliance News] - A Bank of England policymaker has said US trade tariffs are more likely to push down on UK inflation than to push it up, but that there are risks on both sides. Megan Greene told ...

(Alliance News) - Braime Group PLC on Tuesday reported lower profit in 2024 and said the "fraught" economic and geopolitical situation means its outlook is "simply and frankly one of uncertainty". The ...

The Cambridgeshire, England-based biopharmaceutical company reported a pretax loss of GBP10.6 million in 2024, widened from GBP8.9 million in 2023. Revenue was GBP5.1 million, up 10% from GBP4.6 ...